Archana Pillai
To compare and evaluate the price and quality of “branded” and branded-generic equivalents of some commonly used medicines manufactured by the different pharmaceutical company in India. Materials and Methods: Two commonly used medicines: TELMISARTAN and ONDANSETRON manufactured in branded and branded-generic versions by the different company were selected. Price-to-patient and price-to-retailers were found for two “pair” of medicines. Both quantitative and qualitative analysis were performed following the methods prescribed in the Indian Pharmacopoeia on two “pair” of medicines. The tests performed were identification test, dissolution studies. Result & Conclusion Price-to-patient (MRP) for two branded medicines were in the range of 58-23% but for their branded-generics version manufactured by the same companies (PTR) was in the range of 160-16%. Retailer mark-ups for two “pair” of medicines for branded versus branded-generic: telmisartan and ondansetron were 38% versus 160%, 44% versus 16% respectively. Both versions of two medicines were within their permissible range for all the quantitative and qualitative parameters as prescribed in Indian Pharmacopoeia.
English 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi